myfortic is a medicine designed for people who have received a kidney transplant. It helps prevent your body's immune system from rejecting your new kidney, so it can function more normally as part of your body. myfortic delivers the same medicine as CellCept^®, a common kidney antirejection treatment. But myfortic is an enteric-coated formulation of mycophenolic acid (MPA) in a delayed-release tablet. That means that the coating on the tablet keeps it from dissolving in your stomach right after you take it. The active ingredient is not released until it reaches your small intestine. That's the myfortic difference.